| Patent Number |
Title Of Patent |
Date Issued |
| 6949566 |
Thiazole and oxazole derivatives |
September 27, 2005 |
| A compound of the formula (I): ##STR1## wherein R.sup.1 is hydroxy and the like; R.sup.2 is optionally substituted lower alkyl and the like; R.sup.3 is hydrogen atom and the like; R.sup.4 is optionally substituted arylene and the like; R.sup.5 is a group represented by the formula: |
| 6897237 |
MMP-12 inhibitors |
May 24, 2005 |
| A compound of the formula (I): ##STR1##wherein R.sup.1 is hydroxy and the like; R.sup.2 is optionally substituted lower alkyl and the like; R.sup.3 is hydrogen atom and the like; R.sup.4 is optionally substituted arylene and the like; R.sup.5 is --C.ident.C-- and the like; R.sup.6 is |
| 6878739 |
Composition for treating or preventing glomerulopathy |
April 12, 2005 |
| A composition for treating or preventing glomerulopathy which contains a compound of the formula (I): ##STR1##wherein, for example, R.sup.1 and R.sup.2 are each independently hydrogen atom, optionally substituted lower alkyl, optionally substituted aralkyl, etc.; R.sup.3 is 1,4-phe |
| 6727266 |
Substituted tryptophan derivatives |
April 27, 2004 |
| A compound of the formula (I): ##STR1##wherein: R.sup.1 is represented by the formula: ##STR2##wherein R.sup.4, R.sup.5, R.sup.6, R.sup.7 and R.sup.8 are monovalent radicals such as: hydrogen, halogen, optionally substituted lower alkyl, lower alkyloxy, lower alkylthio, optionally su |
| 6720343 |
Oxadiazole derivatives having anticancer effects |
April 13, 2004 |
| A pharmaceutical composition for treating or preventing cancer containing a compound of the general formula (I), a prodrug, a pharmaceutically acceptable salt, or a solvate thereof as an active ingredient: ##STR1##wherein R.sup.1 is hydroxy or the like; R.sup.2 is optionally substituted |
| 6495578 |
Sulfonamide derivatives having oxadiazole rings |
December 17, 2002 |
| Sulfonamide derivatives having a matrix metalloprotease inhibiting effect, which are compounds represented by general formula (I), optical isomers of the same, pharmaceutically acceptable salts of both, or solvates of them: ##STR1##wherein R.sup.1 and R.sup.2 are each independently hydro |
| 6423729 |
Therapeutic or prophylactic agent for glomerulopathy |
July 23, 2002 |
| A composition for treating or preventing glomerulopathy which contains a compound of the formula (I): ##STR1## wherein, for example, R.sup.1 and R.sup.2 are each independently hydrogen atom, optionally substituted lower alkyl, optionally substituted aralkyl, etc.; R.sup.3 is 1, |
| 4525355 |
7-.beta.-Ureidoacetamido-oxacephalosporins |
June 25, 1985 |
| A 7.beta.-ureidoacetamido-7.alpha.-methoxy-3-(1-carbamoylmethyl-1H-tetrazol- 5-yl)thiomethyl-1-dethia-1-oxa-3-cephem-4-carboxylic acid derivative represented by the following formula: ##STR1## wherein Ar is phenyl, hydroxyphenyl, or thienyl and R is hydrogen, a light metal, or |
| 4504658 |
Epimerization of malonic acid esters |
March 12, 1985 |
| A compound represented by the formula (II) epimerizes by the action of a base and the product is precipitated for shifting the equilibrium to yield the corresponding epimer represented by the formula (I). ##STR1## wherein Ar is an optionally substituted aryl or heterocyclic group;Tet |
